{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:40:05Z","timestamp":1778236805445,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["614739"],"award-info":[{"award-number":["614739"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003006","name":"Eidgen\u00f6ssische Technische Hochschule Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jchromb.2021.122556","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T23:24:57Z","timestamp":1611098697000},"page":"122556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: Application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos"],"prefix":"10.1016","volume":"1166","author":[{"given":"Daniela","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somphou","family":"Sayasone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122556_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpddr.2019.06.002","article-title":"Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance","volume":"10","author":"Prichard","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"9","key":"10.1016\/j.jchromb.2021.122556_b0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/BF01971780","article-title":"Avermectins - novel insecticides, acaricides and nematicides from a soil microorganism","volume":"37","author":"Putter","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.jchromb.2021.122556_b0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","article-title":"Moxidectin and the avermectins: Consanguinity but not identity","volume":"2","author":"Prichard","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.jchromb.2021.122556_b0020","series-title":"Sounders Handbook of Veterinary Drugs","first-page":"545","author":"Papich","year":"2016"},{"key":"10.1016\/j.jchromb.2021.122556_b0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(17)32844-1","article-title":"Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial","volume":"392","author":"Opoku","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jchromb.2021.122556_b0030","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/cid\/ciz326","article-title":"Efficacy and safety of ascending dosages of moxidectin and moxidectin-albendazole against Trichuris trichiura in adolescents: A randomized controlled trial","volume":"70","author":"Keller","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122556_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cid\/cix278","article-title":"Efficacy of moxidectin versus ivermectin against Strongyloides stercoralis infections: a randomized, controlled noninferiority trial","volume":"65","author":"Barda","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jchromb.2021.122556_b0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1473-3099(18)30233-0","article-title":"Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial","volume":"18","author":"Barda","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.jchromb.2021.122556_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004389","article-title":"Prospects for moxidectin as a new oral treatment for human scabies","volume":"10","author":"Mounsey","year":"2016","journal-title":"PLoS Negl. Trop Dis."},{"issue":"10","key":"10.1016\/j.jchromb.2021.122556_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005030","article-title":"Preclinical study of single-dose moxidectin, a new oral treatment for scabies: efficacy, safety, and pharmacokinetics compared to two-dose ivermectin in a porcine model","volume":"10","author":"Bernigaud","year":"2016","journal-title":"PLoS Negl. Trop Dis."},{"issue":"6","key":"10.1016\/j.jchromb.2021.122556_b0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.14411\/fp.2014.068","article-title":"Moxidectin causes adult worm mortality of human lymphatic filarial parasite Brugia malayi in rodent models","volume":"61","author":"Verma","year":"2014","journal-title":"Folia Parasitol. (Praha)"},{"key":"10.1016\/j.jchromb.2021.122556_b0060","unstructured":"Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases, 2010: p. 147\u2013151."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122556_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14787210.7.1.37","article-title":"Prospects for the control of neglected tropical diseases by mass drug administration","volume":"7","author":"Smits","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122556_b0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12992-017-0306-9","article-title":"Patent landscape of neglected tropical diseases: an analysis of worldwide patent families","volume":"13","author":"Akinsolu","year":"2017","journal-title":"Global Health"},{"issue":"11","key":"10.1016\/j.jchromb.2021.122556_b0075","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/ijerph16111925","article-title":"Emerging resistance of neglected tropical diseases: a scoping review of the literature","volume":"16","author":"Akinsolu","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.jchromb.2021.122556_b0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-4017(94)00743-V","article-title":"Structure and activity of avermectins and milbemycins in animal health","volume":"59","author":"Shoop","year":"1995","journal-title":"Vet. Parasitol."},{"issue":"14","key":"10.1016\/j.jchromb.2021.122556_b0085","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1021\/ja00404a040","article-title":"Avermectins - structure determination","volume":"103","author":"Albersschonberg","year":"1981","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.jchromb.2021.122556_b0090","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/0091270003257456","article-title":"The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans","volume":"43","author":"Cotreau","year":"2003","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122556_b0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cpdd.81","article-title":"Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects","volume":"3","author":"Korth-Bradley","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122556_b0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/2160763X11432508","article-title":"Relative bioavailability of liquid and tablet formulations of the antiparasitic moxidectin","volume":"1","author":"Korth-Bradley","year":"2012","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"11","key":"10.1016\/j.jchromb.2021.122556_b0105","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/AAC.00311-11","article-title":"Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women","volume":"55","author":"Korth-Bradley","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122556_b0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4269\/ajtmh.2012.11-0415","article-title":"The effect of a high-fat breakfast on the pharmacokinetics of moxidectin in healthy male subjects: a randomized phase I trial","volume":"86","author":"Korth-Bradley","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.jchromb.2021.122556_b0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/cts.12583","article-title":"Evaluation of the cardiac safety of long-acting endectocide moxidectin in a randomized concentration-QT study","volume":"11","author":"Kinrade","year":"2018","journal-title":"Clin. Transl. Sci."},{"issue":"5","key":"10.1016\/j.jchromb.2021.122556_b0120","first-page":"238","article-title":"Determining the optimal dose of moxidectin for onchocerciasis via pharmacokinetic-pharmacodynamic (PK-PD) modelling of data from healthy volunteers and patients with onchocerciasis","volume":"97","author":"Jamsen","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.jchromb.2021.122556_b0125","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0731-7085(02)00120-6","article-title":"Liquid chromatographic assay of moxidectin in human plasma for application to pharmacokinetic studies","volume":"29","author":"Chen","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122556_b0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4347(95)00294-5","article-title":"Determination of moxidectin in plasma by high-performance liquid-chromatography with automated solid-phase extraction and fluorescence detection","volume":"674","author":"Alvinerie","year":"1995","journal-title":"J. Chromatography B-Biomed. Appl."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122556_b0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1258\/la.2009.009053","article-title":"Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits","volume":"44","author":"Gokbulut","year":"2010","journal-title":"Lab. Anim."},{"issue":"1\u20132","key":"10.1016\/j.jchromb.2021.122556_b0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2006.11.014","article-title":"Positive and negative electrospray LC-MS\/MS methods for quantitation of the antiparasitic endectocide drugs, abamectin, doramectin, emamectin, eprinomectin, ivermectin, moxidectin and selamectin in milk","volume":"850","author":"Durden","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"10","key":"10.1016\/j.jchromb.2021.122556_b0145","first-page":"1313","article-title":"Development and validation of LC-MS\/MS method to determine the residue of veterinary drugs ivermectin, doramectin and moxidectin in milk","volume":"52","author":"Dahiya","year":"2013","journal-title":"Indian J. Chem. Section B-Org. Chem. Including Med. Chem."},{"issue":"4","key":"10.1016\/j.jchromb.2021.122556_b0150","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jaoac\/89.4.1088","article-title":"Determination of abamectin, doramectin, emamectin, eprinomectin, ivermectin, and moxidectin in milk by liquid chromatography electrospray tandem mass specrometry","volume":"89","author":"Sheridan","year":"2006","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2021.122556_b0155","unstructured":"Agilent Technologies, I. Development of an Analytical Method for Determination of Antiparasitic Residues in Milk Uinsg QuEChERS and Analysis by LC-MS\/MS. [Application Note] [cited 2020 10.09.2020]; Available from: https:\/\/www.agilent.com\/cs\/library\/applications\/5991-3948EN.pdf."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122556_b0160","doi-asserted-by":"crossref","first-page":"e4389","DOI":"10.1002\/bmc.4389","article-title":"Bioanalytical method development and validation of moxidectin in plasma by LC-MS\/MS: Application to in vitro metabolism","volume":"33","author":"Chhonker","year":"2019","journal-title":"Biomed. Chromatogr."},{"issue":"113102","key":"10.1016\/j.jchromb.2021.122556_b0165","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: Special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jchromb.2021.122556_b0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4155\/bio-2017-0269","article-title":"Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review","volume":"10","author":"Guerra Valero","year":"2018","journal-title":"Bioanalysis"},{"issue":"10","key":"10.1016\/j.jchromb.2021.122556_b0175","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4155\/bio-2019-0041","article-title":"Microsampling: considerations for its use in pharmaceutical drug discovery and development","volume":"11","author":"Spooner","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2021.122556_b0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: Current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122556_b0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1208\/s12248-014-9695-3","article-title":"Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group","volume":"17","author":"Evans","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2021.122556_b0190","doi-asserted-by":"crossref","unstructured":"D. Hofmann, S. Sayasone, K. Sengngam, B. Chongvilay, J. Hattendorf, J. Keiser, Efficacy and safety of ascending dosages of moxidectin against Strongyloides stercoralis infections in adults: a randomized, blinded, placebo-controlled, dose-ranging, phase 2a trial, (2021) Lancet Infect Diseases (in press).","DOI":"10.1016\/S1473-3099(20)30691-5"},{"key":"10.1016\/j.jchromb.2021.122556_b0195","series-title":"Products for Human Use (CHMP). Guideline on Bioanalytical Method Validation","year":"2011"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:03:03Z","timestamp":1761606183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"alternative-id":["S1570023221000350"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122556","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: Application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122556"}}